ESR2 and cancer: In common with other members of the nuclear receptor family (van der Vaart & Schaaf 2009), the ESR1 and ESR2 genes are subject to alternative splicing with both C terminal and exon-skipping isoforms identified in cancer cell lines and human tissues including the testis (Saunders et al. 2002).